DHR Danaher Corporation
USHealthcareAs of 2026-10-08
Why DHR matters now
Danaher Corporation (DHR) is a US stock in Healthcare. The latest InvestLog snapshot shows $217.46 with -0.47% on the session and $152.87B in market capitalization; recent performance reads 1-month +6.06% and YTD -22.61%.
The latest financial table shown here is Q1 2026, with revenue of $5.95B, net income of $1.03B, and EPS of $1.45. Investors can compare that operating picture with valuation signals such as P/E 37.10 and FCF yield 4.2%.
InvestLog's latest related AI research is a Rating Change note titled "RBC Capital raises DHR target to $250 from $215". The latest indexable market news headline is "Chickasaw Capital Management LLC Buys 2,600 Shares of Danaher Corporation DHR" from Defense World.
Additional event context on this page matters because analyst consensus is Buy with a median target of $230.00; recent insider activity includes Lamanna Charles W filing A-Award; recent congressional disclosure data includes Michael McCaul Purchase. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
37.10
PEG
—
P/B
2.37
P/S
5.06
EV/EBITDA
20.80
DCF Value
$223.00
FCF Yield
4.2%
Div Yield
0.8%
Margins & Returns
Gross Margin
60.7%
Operating Margin
21.0%
Net Margin
14.9%
ROE
7.1%
ROA
4.4%
ROIC
5.7%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $5.95B | $1.03B | $1.45 |
| Q4 2025 | $6.84B | $1.20B | $1.68 |
| FY 2025 | $24.57B | $3.61B | $5.04 |
| Q3 2025 | $6.05B | $908.0M | $1.27 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$230.89
Target (Median)
$230.00
Target Range
$200.00 - $265.00
Trading Activity
Insider Trades
Congress Trades
Related AI Research
RBC Capital raises DHR target to $250 from $215RBC Capital 上调目标价 丹纳赫公司 (DHR):$215 → $250
On 2026-10-05, RBC Capital raised its DHR price target to $250 from $215 (+16.3%).RBC Capital 于 2026-10-05 将 DHR 目标价上调至 $250,此前为 $215,变动幅度 +16.3%。
Danaher Corporation (DHR) falls 4.07% to $212.54Danaher Corporation(DHR)下跌 4.07%,报 $212.54
Danaher Corporation (DHR) traded 4.07% lower at $212.54 as of 2026-10-01T18:05:53+00:00. Reported session volume was 2,262,954 shares, or approximately $481M in turnover.Danaher Corporation(DHR)截至 2026-10-01T18:05:53+00:00 下跌 4.07%,报 $212.54。当日成交量为 2,262,954 股,成交额估算约 $481M。
Guggenheim raises DHR target to $250 from $200Guggenheim 上调目标价 丹纳赫公司 (DHR):$200 → $250
On 2026-10-01, Guggenheim raised its DHR price target to $250 from $200 (+25.0%).Guggenheim 于 2026-10-01 将 DHR 目标价上调至 $250,此前为 $200,变动幅度 +25.0%。
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Country
US
Exchange
—
Beta
0.83
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.